Impact of long-term immunosuppression with cyclosporin A on serum lipids in stable renal transplant recipients
- 1 January 1991
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 4 (1), 92-95
- https://doi.org/10.1111/j.1432-2277.1991.tb01955.x
Abstract
To determine the impact of long‐term immunosuppression on serum lipids in stable renal graft recipients we measured serum lipids and apolipoprotein B concentrations in 20 patients receiving therapy with cyclosporin (CsA) and low‐dose prednisolone (CsA/P) and in 18 patients on therapy with azathioprine and maintenance steroids (Aza/P). The patients were matched for age, body mass index, primary renal disease and dose of prednisolone, but not for the duration in transplantation and serum creatinine concentration. Triglyceride concentrations were significantly higher in the CsA/P group than in Aza/P‐treated patients: 2.62 ± 0.35 vs 1.62 ± 0.23 mmol/l (P< 0.05). Similarly, total cholesterol (C) levels were significantly more elevated in the CsA/P recipients than in the other group: 7.4410.32 vs 5.84 ± 0.25 (FP < 0.001) and apolipoprotein B concentrations (191 ± 13 vs 128 ± 9 mg/dl; P< 0.001). CsA/P and Aza/P recipients had similar concentrations of HDL‐C (1.73 ± 0.13 vs 1.52 ± 0.09 mmol/l; NS). We conclude that in stable renal graft recipients with good transplant function long‐term immunosuppression with CsA/P is associated with a more atherogenic lipid status than therapy with Aza/P.Keywords
This publication has 19 references indexed in Scilit:
- Paracrine/Autocrine Regulation of Anion Secretion in the Epididymis: Role of Angiotensin IINeurosignals, 1996
- More on Rifampin Prophylaxis againstHaemophilus influenzaeb in Day-Care FacilitiesNew England Journal of Medicine, 1988
- Rhabdomyolysis in Patients Receiving Lovastatin after Cardiac TransplantationNew England Journal of Medicine, 1988
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988
- Persistent Hyperlipidemia in Renal Transplant PatientsMedicine, 1987
- CYCLOSPORIN CONVERSION VERSUS CONVENTIONAL IMMUNOSUPPRESSION: LONG-TERM FOLLOW-UP AND HISTOLOGICAL EVALUATIONThe Lancet, 1987
- Cyclosporine nephrotoxicityKidney International, 1986
- SERUM CHOLESTEROL, BLOOD PRESSURE, AND MORTALITY: IMPLICATIONS FROM A COHORT OF 361 662 MENThe Lancet, 1986
- HIGH CYCLOSPORIN LEVELS AFTER BONE MARROW TRANSPLANTATION ASSOCIATED WITH HYPERTRIGLYCERIDAEMIAThe Lancet, 1986
- Interaction of cyclosporin A with human lipoproteinsJournal of Pharmacy and Pharmacology, 1986